bis-cyclopropanecarbonyl-amine | 10528-56-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: bis-cyclopropanecarbonyl-amine
• 英文别名: Bis-cyclopropancarbonyl-amin；Dicyclopropanecarboxamide；N-(cyclopropanecarbonyl)cyclopropanecarboxamide
• CAS: 10528-56-0
• 化学式: C₈H₁₁NO₂
• 分子量: 153.181
• InChiKey: RLPDHOAILQJTHX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  46.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  环丙基甲酸乙酯 在 sodium amide 、 甲苯 作用下， 生成 bis-cyclopropanecarbonyl-amine
  参考文献：
  名称：

  Alkylation of Cyclopropyl Phenyl Ketone

  摘要：

  DOI：

  10.1021/ja01116a040

文献信息

• [EN] cMET INHIBITORS<br/>[FR] INHIBITEURS DE CMET
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2010019899A1

  公开（公告）日：2010-02-18

  Compounds of the following formula are provided for use with cMET: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

  提供以下公式的化合物供与cMET一起使用：其中变量如本文所定义。还提供包含这些化合物的药物组合物、试剂盒和制造物品；用于制备这些化合物的有用中间体和方法；以及使用这些化合物的方法。
• [EN] THIENYLPYRI(MI)DINYLPYRAZOLE<br/>[FR] THIÉNYLPYRI(MI)DINYLPYRAZOLE
  申请人：BAYER IP GMBH

  公开号：WO2012175513A1

  公开（公告）日：2012-12-27

  Thienylpyri(mi)dinylpyrazole of the formula (I) in which R1 to R8 and X1 have the meanings given in the description, and agrochemically active salts, to their use and to methods and compositions for controlling phytopathogenic harmful fungi in and/or on plants or in and/or on seed of plants and for reducing mycotoxins in plants and parts of the plants, to processes for preparing such compounds and compositions and treated seed and also to their use for controlling phytopathogenic harmful fungi in agriculture, horticulture, forestry, in animal husbandry, in the protection of materials, in the domestic and hygiene field and for the reduction of mycotoxins in plants and parts of the plants

  化学式为（I）的噻吩基吡啶基吡唑，其中R1至R8和X1的含义如描述中所示，以及农用活性盐，其用途以及用于控制植物和/或植物种子中的植物病原真菌的方法和组合物，以及减少植物和植物部分中的霉菌毒素，用于制备此类化合物和组合物以及处理后的种子的方法，以及其在农业、园艺、林业、畜牧业、材料保护、家庭卫生领域中用于控制植物病原真菌和减少植物和植物部分中的霉菌毒素。
• [EN] THIENYLPYRI (MI) DINYLAZOLE AND THEIR USE FOR CONTROLLING PHYTOPATHOGENIC FUNGI<br/>[FR] THIÉNYLPYRI(MI)DINYLAZOLE ET UTILISATION ASSOCIÉE DANS LA LUTTE CONTRE DES CHAMPIGNONS PHYTOPATHOGÈNES
  申请人：BAYER CROPSCIENCE AG

  公开号：WO2011076725A1

  公开（公告）日：2011-06-30

  Thienylpyri(mi)dinylazole of the formula (I) in which R1 to R8 and X1 have the meanings given in the description, and agrochemically active salts, to their use and to methods and compositions for controlling phytopathogenic harmful fungi in and/or on plants or in and/or on seed of plants and for reducing mycotoxins in plants and parts of the plants, to processes for preparing such compounds and compositions and treated seed and also to their use for controlling phytopathogenic harmful fungi in agriculture, horticulture, forestry, in animal husbandry, in the protection of materials, in the domestic and hygiene field and for the reduction of mycotoxins in plants and parts of the plants.

  该文描述了化合物公式（I）中的Thienylpyri（mi）dinylazole，其中R1至R8和X1的含义在描述中给出，以及其农药活性盐，其用途以及用于控制植物或种子中和/或植物或其部位中的植物病原真菌和减少植物中真菌毒素的方法和组合物，以及制备此类化合物和组合物以及处理过的种子的过程，也包括它们在农业、园艺、林业、畜牧业、材料保护、家庭和卫生领域中控制植物病原真菌和减少植物及其部位中真菌毒素的用途。
• Condensed Imidazole Compound And Use Thereof
  申请人：Uchikawa Osamu

  公开号：US20080167314A1

  公开（公告）日：2008-07-10

  The present invention relates to a compound represented by the formula [I] wherein X 1 , X 2 and X 3 are each an optionally substituted CH or a nitrogen atom, and any one of X 1 , X 2 and X 3 is a nitrogen atom, X 4 is an optionally substituted CH, R 1 is an optionally substituted phenyl group or an optionally substituted heterocyclic group, and R 2 is an optionally substituted pyridin-4-yl group, an optionally substituted pyridine-N-oxide-4-yl group or an optionally substituted pyrimidin-4-yl group, or a salt thereof. The compound has superior p38 MAP kinase inhibitory activity and MMP-13 production inhibitory activity, and is useful as an agent for the prophylaxis or treatment and the like of an inflammatory disease, an autoimmune disease, a debilitating disease, an osteoarticular degenerative disease, a neurodegenerative disease, a vascular disease, a neoplastic disease or an infectious disease.

  本发明涉及一种化合物，其表示为式[I]，其中X1、X2和X3分别是可选取代的CH或氮原子，且X1、X2和X3中的任意一个是氮原子，X4是可选取代的CH，R1是可选取代的苯基或可选取代的杂环基，R2是可选取代的吡啶-4-基、可选取代的吡啶-N-氧化物-4-基或可选取代的嘧啶-4-基，或其盐。该化合物具有优异的p38 MAP激酶抑制活性和MMP-13产生抑制活性，可用作预防或治疗炎症性疾病、自身免疫疾病、虚弱性疾病、骨关节退行性疾病、神经退行性疾病、血管疾病、肿瘤性疾病或感染性疾病的药物等。
• cMET INHIBITORS
  申请人：Bressi Jerome C.

  公开号：US20100063054A1

  公开（公告）日：2010-03-11

  Compounds of the following formula are provided for use with cMET: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

  提供以下公式化合物用于cMET的使用：其中变量如此处所定义。还提供了包含这些化合物的制药组合物、工具箱和制造物品，以及用于制造这些化合物的有用中间体和方法，以及使用这些化合物的方法。